Cart
sales@molnova.com
(4-NH2)-Exatecan
CAS No. 2495742-21-5
(4-NH2)-Exatecan( —— )
Catalog No. M35185 CAS No. 2495742-21-5
(4-NH2)-Exatecan is a topoisomerase inhibitor with potential anticancer activity for the synthesis of antibody drug conjugates (ADCs).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 282 | In Stock |
|
| 10MG | 471 | In Stock |
|
| 25MG | 708 | In Stock |
|
| 50MG | 918 | In Stock |
|
| 100MG | 1349 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(4-NH2)-Exatecan
-
NoteResearch use only, not for human use.
-
Brief Description(4-NH2)-Exatecan is a topoisomerase inhibitor with potential anticancer activity for the synthesis of antibody drug conjugates (ADCs).
-
Description(4-NH2)-Exatecan, a topoisomerase inhibitor, is a derivative of Exatecan. (4-NH2)-Exatecan can be used in the synthesis of antibody-drug conjugates (ADCs) (US20200306243A1, compound A).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAntibody Drug Conjugates (ADC)
-
TargetADC Cytotoxin
-
RecptorADC Cytotoxin | Topoisomerase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2495742-21-5
-
Formula Weight403.43
-
Molecular FormulaC23H21N3O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (247.87 mM; Ultrasonic )
-
SMILESCC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(N)c5CCCc(c3Cn1c2=O)c45
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Howard PW, et, al. Compounds and conjugates thereof. US20200306243A1.
molnova catalog
related products
-
PNU-159682
A highly potent metabolite of the anthracycline nemorubicin with outstanding cytotoxicity; a topoisomerase inhibitor and ADCs cytotoxin.
-
AXC-666
AXC-666 is a TLR agonist and an immuno agonist that can be used to synthesize antibody drug couplers (ADCs).
-
SGD-1882
SGD-1882 (PBD dimer, Pyrrolobenzodiazepine dimer) is a novel potent DNA-intercalating payload dimer (PBD dimer) payload for antibody-drug conjugates (ADCs).
